Breaking News, Collaborations & Alliances

MoD Contracts Plasticell for Pilot Program

To develop regenerative medicines for the treatment of injuries resulting from combat or terrorism

Plasticell Ltd has been contracted by the Ministry of Defence (MoD) in a pilot program to develop regenerative medicines for the treatment of injuries resulting from combat or terrorism.   Plasticell will deploy its combinatorial stem cell screening platform, CombiCult®, to develop technologies for the conversion of pluripotent stem cells into platelets that promote tissue recovery and regeneration.   “This defence-related work is an extension of Plasticell’s programme for manufacture of u...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters